Search Results
Search for other papers by J Finidori in
Google Scholar
PubMed
Search for other papers by P A Kelly in
Google Scholar
PubMed
Introduction
Cytokines are chemical mediators that include interleukins, polypeptide hormones and other growth factors. They regulate growth, differentiation and specific cellular functions by interacting with their cognate receptors. Cytokine receptors, which contain no tyrosine kinase domain in their cytoplasmic regions, have been grouped into different classes (Bazan 1990, Kitamura et al. 1994). The haematopoietic or cytokine/growth hormone/prolactin receptor family (Class I) and the interferon family (Class II) share both structural features and newly identified common signal transduction pathways. In the last 2 years, it has been demonstrated that both classes of receptors are associated with various members of the Janus kinase (JAK) family and activate a new family of transcription factors that couple ligand binding to the activation of gene expression and are thus termed signal transducers and activators of transcription (STATs) (Shuai et al. 1993a).
Structure of cytokine receptors
Class I and Class II cytokine receptors appear to
Search for other papers by RT Boudreau in
Google Scholar
PubMed
Search for other papers by SM Sangster in
Google Scholar
PubMed
Search for other papers by LM Johnson in
Google Scholar
PubMed
Search for other papers by S Dauphinee in
Google Scholar
PubMed
Search for other papers by AW Li in
Google Scholar
PubMed
Search for other papers by CK Too in
Google Scholar
PubMed
A prolactin (PRL)-responsive 3'-end cDNA encoding rat alpha4 phosphoprotein was previously isolated from a rat lymphoma cDNA library. Rat alpha4 is a homologue of yeast Tap42 and is a component of the mammalian target-of-rapamycin (mTOR) signalling pathway that stimulates translation initiation and G1 progression in response to nutrients and growth factors. In the present study, the full-length rat alpha4 cDNA was obtained by 5'-RACE and the 1023 bp open reading frame predicted a 340 amino acid protein of 39.1 kDa. The alpha4 mRNA was expressed in quiescent PRL-dependent Nb2 lymphoma cells deprived of PRL for up to 72 h but expression was downregulated within 4 h of PRL treatment. In contrast, PRL-independent Nb2-Sp cells showed constitutive expression of alpha4 that was not affected by PRL. Western analysis of Nb2 cell lysates or of V5-tagged-alpha4 expressed in COS-1 cells detected a single immunoreactive band of approximately 45 kDa. Enzymatic deglycosylation of affinity-purified 45 kDa alpha4 yielded the predicted 39 kDa protein. Phosphorylation of Nb2 alpha4 was induced by PRL or 2-O-tetradecanoyl-phorbol-13-acetate (TPA) and further enhanced by a combination of PRL and TPA. The Nb2 alpha4 associated with the catalytic subunit of protein phosphatase 2A and localized predominantly in Nb2 nuclear fractions with trace amounts in the cytosol. The immunosuppressant drug rapamycin inhibited proliferation of Nb2 cells in response to PRL or interleukin-2, but had no effect on Nb2-Sp cells. Furthermore, transient overexpression of alpha4 in COS-1 cells inhibited PRL stimulation of the immediate-early gene interferon regulatory factor-1 promoter activity. Therefore, PRL downregulation of alpha4 expression and/or PRL-inducible phosphorylation of alpha4 may be necessary for PRL receptor (PRLr) signalling to the interferon regulatory factor-1 promoter in the Nb2 cells and, furthermore, implicates cross-talk between the mTOR and PRLr signalling cascades during Nb2 cell mitogenesis.
Search for other papers by A. P. Weetman in
Google Scholar
PubMed
Search for other papers by R. Bright-Thomas in
Google Scholar
PubMed
Search for other papers by M. Freeman in
Google Scholar
PubMed
ABSTRACT
Autoimmune thyroiditis is characterized by lymphocytic accumulation within the thyroid which may be the result, in part, of immunomodulatory cytokine secretion by thyrocytes. We have tested human thyroid cell cultures (n = 9) for interleukin-6 (IL-6) release using two bioassays. IL-6 was detected in all culture supernatants under basal conditions and was increased by γ-interferon, tumour necrosis factor and TSH in a dose-dependent manner. The bioactivity was confirmed as IL-6 by immunoblotting experiments and could not be accounted for by contamination of the thyroid cell cultures with fibroblasts, lymphocytes or monocytes. Circulating IL-6 levels were not raised in patients with Graves' hyperthyroidism. Exogenous recombinant IL-6 reduced cyclic AMP production in response to TSH when added to thyroid cell cultures. Since IL-6 plays a major role in B cell differentiation and T cell activation, release of IL-6 by thyrocytes may increase the intrathyroidal autoimmune response in Graves' disease and Hashimoto's thyroiditis. Our results also suggest that IL-6 may modulate thyroid cell function.
Journal of Endocrinology (1990) 127, 357–361
Search for other papers by J. L. Vallet in
Google Scholar
PubMed
Search for other papers by F. W. Bazer in
Google Scholar
PubMed
Search for other papers by C.J. Ashworth in
Google Scholar
PubMed
Search for other papers by H. M. Johnson in
Google Scholar
PubMed
Search for other papers by C. H. Pontzer in
Google Scholar
PubMed
ABSTRACT
A radioimmunoassay has been developed for quantitation of ovine trophoblast protein-1 (oTP-1), a sheep conceptus secretory protein which allows for maintenance of the corpus luteum during early pregnancy. The assay was validated for dialysed and undialysed culture medium and pregnant uterine flushings ranging from no dilution (neat) to dilutions of 1:2500 for dialysed media, 1:100-1:1000 for undialysed media and 1:50-1:1000 for pregnant uterine flushings. The assay accurately measured oTP-1 added to undiluted and diluted dialysed and undialysed culture media and pregnant uterine flushings. No cross-reaction was detectable for bovine α or γ interferon, bovine calmodulin, feline conceptus secretory proteins, equine conceptus secretory proteins, porcine conceptus secretory proteins, bovine conceptus secretory proteins and proteins in a uterine flushing collected from a non-pregnant ewe. Immunoreactivity in the assay matched that for oTP-1 throughout oTP-1 purification. This assay is the first validated assay which may be used to quantitate production of oTP-1 in culture or content of oTP-1 in uterine flushings.
Search for other papers by N. Tandon in
Google Scholar
PubMed
Search for other papers by C. Dinsdale in
Google Scholar
PubMed
Search for other papers by T. Tamatani in
Google Scholar
PubMed
Search for other papers by M. Miyasaka in
Google Scholar
PubMed
Search for other papers by A. P. Weetman in
Google Scholar
PubMed
ABSTRACT
We have examined the expression and function of rat CD54, a homologue of human intercellular adhesion molecule-1 (ICAM-1), by the continuously growing rat thyroid cell line FRTL-5. Approximately 10% of FRTL-5 cells express CD54 under basal conditions and this is not influenced by thyrotrophin. Expression of CD54 is increased by cytokines (γ-interferon, tumour necrosis factor, interleukin-1) and by an activator of C-kinase, phorbol 12-myristate 13-acetate. Blocking ICAM-1 with a monoclonal antibody directed against this molecule significantly (P <0·01) reduced the binding of splenic lymphocytes to FRTL-5 cells but inhibition was consistently greater (P <0·01) in the presence of antibodies against a rat homologue of lymphocyte function-associated antigen-1, the receptor on T cells for ICAM-1. In no case was complete blocking of cluster formation observed. These results show that a pure line of rat thyroid cells can express an ICAM-1 homologue and this is directly enhanced by cytokines. Expression of this homologue is partially responsible for lymphocyte adhesion to thyroid cells, which is likely to be a major event in T cell recognition of thyroid antigens in autoimmune thyroiditis.
Journal of Endocrinology (1991) 130, 451–456
Search for other papers by D. Janjic in
Google Scholar
PubMed
Search for other papers by M. Asfari in
Google Scholar
PubMed
ABSTRACT
To investigate further the role of cytokines in the pathogenesis of type I insulin-dependent diabetes mellitus, the effects of interleukin-1β (IL-1), tumour necrosis factor-α (TNF) and γ-interferon (IFN) were tested on rat insulinoma INS-1 cells. Whereas TNF and IFN had, respectively, a minor or no effect on insulin production, IL-1 caused a time- and dose-dependent decrease in insulin release and lowered the insulin content as well as the preproinsulin mRNA content of INS-1 cells. Both IL-1 and TNF exerted a cytostatic effect, estimated by a decrease in [3H]thymidine incorporation, while only IL-1 decreased cell viability as measured by the colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test.
The glutathione content of INS-1 cells was shown to be modulated by the presence of 2-mercaptoethanol in the culture medium, but was not affected by IL-1 or TNF.
In conclusion, INS-1 cell culture is considered to be a useful model for studying the effect of cytokines on insulin-producing cells. The differentiated features of these cells will permit several questions to be addressed regarding the mechanism of action of IL-1 and eventually other cytokines, both at the level of gene expression and of intracellular signalling.
Journal of Endocrinology (1992) 132, 67–76
Search for other papers by Ch. Müller in
Google Scholar
PubMed
Search for other papers by C. C. Zielinski in
Google Scholar
PubMed
Search for other papers by W. Kalinowski in
Google Scholar
PubMed
Search for other papers by H. Wolf in
Google Scholar
PubMed
Search for other papers by J. W. Mannhalter in
Google Scholar
PubMed
Search for other papers by G. Aschauer-Treiber in
Google Scholar
PubMed
Search for other papers by D. Klösch-Kasparek in
Google Scholar
PubMed
Search for other papers by S. Gaube in
Google Scholar
PubMed
Search for other papers by M. M. Eibl in
Google Scholar
PubMed
Search for other papers by G. Schernthaner in
Google Scholar
PubMed
ABSTRACT
Patients who had been included in a randomized double-blind placebo-controlled trial on the efficacy of cyclosporin A (CyA) in producing remissions in insulin-dependent diabetes mellitus (IDDM) type I were investigated for humoral and cellular immunologic parameters. Whereas metabolic derangement before the initiation of insulin treatment led to small but significant decreases in the percentage of CD4-positive lymphocytes as well as of the activity of natural killer (NK) cells and antibody-dependent cellular cytotoxicity (ADCC), the administration of CyA did not influence any of the immunologic parameters tested, which included proliferative lymphocyte responses to mitogens and alloantigens and serum concentrations of immunoglobulins G, A and M. Thus NK cell activity, ADCC as well as the percentage of CD4-positive lymphocytes returned to normal levels in parallel with the normalization of glycosylated haemoglobin (HbAlc), but were not further influenced in their course by the administration of CyA, as compared with patients receiving placebo. Interferon-induced augmentation of NK cell activity did not differ between patients with IDDM on placebo and those under CyA therapy. All other investigated parameters also remained unchanged during the time of CyA therapy. We conclude that metabolic derangement leads to a reversible disturbance of certain cellular immune functions, but their normalization achieved by insulin treatment and their further course remains uninfluenced by the administration of CyA.
Journal of Endocrinology (1989) 121, 177–183
Search for other papers by MR Kritzik in
Google Scholar
PubMed
Search for other papers by E Jones in
Google Scholar
PubMed
Search for other papers by Z Chen in
Google Scholar
PubMed
Search for other papers by M Krakowski in
Google Scholar
PubMed
Search for other papers by T Krahl in
Google Scholar
PubMed
Search for other papers by A Good in
Google Scholar
PubMed
Search for other papers by C Wright in
Google Scholar
PubMed
Search for other papers by H Fox in
Google Scholar
PubMed
Search for other papers by N Sarvetnick in
Google Scholar
PubMed
We have observed pancreatic duct cell proliferation and islet regeneration in transgenic mice whose pancreata produce interferon gamma (IFNg mice). We have previously demonstrated that new islet cells derive from endocrine progenitor cells in the pancreatic ducts of this model. The current study was initiated to define these endocrine progenitor cells further and to identify novel markers associated with pancreatic regeneration. Importantly, we have found that PDX-1, a transcription factor required for insulin gene transcription as well as for pancreatic development during embryogenesis, is expressed in the duct cells of IFNg mice. This striking observation suggests an important role for PDX-1 in the marked regeneration observed in IFNg mice, paralleling its critical function during ontogeny. Also demonstrated was elevated expression of the homeobox-containing protein Msx-2 in the pancreata of fetal mice as well as in adult IFNg mice, identifying this molecule as a novel marker associated with pancreatic development and regeneration as well. The identification of PDX-1 and Msx in the ducts of the IFNg transgenic pancreas but not in the ducts of the non-transgenic pancreas suggests that these molecules are associated with endocrine precursor cells in the ducts of the IFNg transgenic mouse.
Search for other papers by MR Kritzik in
Google Scholar
PubMed
Search for other papers by T Krahl in
Google Scholar
PubMed
Search for other papers by A Good in
Google Scholar
PubMed
Search for other papers by D Gu in
Google Scholar
PubMed
Search for other papers by C Lai in
Google Scholar
PubMed
Search for other papers by H Fox in
Google Scholar
PubMed
Search for other papers by N Sarvetnick in
Google Scholar
PubMed
We have characterized expression of the ErbB receptor family and one of its ligands, heregulin, in an effort to identify molecules associated with pancreatic development and regeneration. In addition to studying expression during fetal pancreatic development, we have also studied expression during pancreatic regeneration in the interferon-gamma (IFNgamma)-transgenic mouse, which exhibits significant duct cell proliferation and new islet formation. These studies demonstrate significant expression of the ErbB2, ErbB3, and ErbB4 receptors, in addition to heregulin isoforms, in the developing murine fetal pancreas. We also report significant ductal expression of these proteins during IFNgamma-mediated pancreatic regeneration. This striking expression was absent in 1-week-old neonates, but was clearly visible in pups by 5 weeks of age. These data therefore indicate that ErbB receptor and ligand expression decline by birth in both the IFNbeta-transgenic and non-transgenic mice, and that expression resumes early in postnatal life in the IFNbeta-transgenic mice. The expression of ErbB receptor family members at sites of islet development and regrowth suggests that these molecules might be relevant to these processes.
Search for other papers by ML Krakowski in
Google Scholar
PubMed
Search for other papers by MR Kritzik in
Google Scholar
PubMed
Search for other papers by EM Jones in
Google Scholar
PubMed
Search for other papers by T Krahl in
Google Scholar
PubMed
Search for other papers by J Lee in
Google Scholar
PubMed
Search for other papers by M Arnush in
Google Scholar
PubMed
Search for other papers by D Gu in
Google Scholar
PubMed
Search for other papers by B Mroczkowski in
Google Scholar
PubMed
Search for other papers by N Sarvetnick in
Google Scholar
PubMed
The upregulation of a limited number of growth factors in our interferon-gamma transgenic model for regeneration within the pancreas lead us to propose that these factors are important during pancreatic regeneration. In this study, we have assessed the influence of two growth factors within the pancreas, epidermal growth factor (EGF) and keratinocyte growth factor (KGF), by ectopically expressing these proteins under the control of the human insulin promoter in transgenic mice. This beta-cell-targeted expression of either EGF or KGF resulted in significant morphological changes, including cellular proliferation and disorganized islet growth. Intercrossing the individual Ins-EGF and Ins-KGF transgenic mice resulted in more profound changes in pancreatic morphology including proliferation of pancreatic cells and extensive intra-islet fibrosis. Insulin-producing beta-cells were found in some of the ducts of older Ins-EGF and Ins-EGFxKGF transgenic mice, and amylase-producing cells were observed within the islet structures of the double transgenic mice. These data suggest that both EGF and KGF are capable of affecting pancreatic differentiation and growth, and that co-expression of these molecules in islets has a more substantial impact on the pancreas than does expression of either growth factor alone.
